These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32155620)

  • 21. [Trend in buprenorphine and methadone shopping behavior in France from 2004 to 2014].
    Kernisant M; Delorme J; Kabore JL; Brousse G; Laporte C; Zenut M; Chenaf C; Authier N
    Presse Med; 2016 Dec; 45(12 Pt 1):e369-e375. PubMed ID: 27823911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphine.
    Moatti JP; Souville M; Escaffre N; Obadia Y
    Addiction; 1998 Oct; 93(10):1567-75. PubMed ID: 9926562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why buprenorphine is so successful in treating opiate addiction in France.
    Fatseas M; Auriacombe M
    Curr Psychiatry Rep; 2007 Oct; 9(5):358-64. PubMed ID: 17915074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study.
    Dupouy J; Palmaro A; Fatséas M; Auriacombe M; Micallef J; Oustric S; Lapeyre-Mestre M
    Ann Fam Med; 2017 Jul; 15(4):355-358. PubMed ID: 28694272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National trends in buprenorphine prescribing before and during the COVID-19 pandemic.
    Ali MM; Creedon TB; Jacobus-Kantor L; Sherry TB
    J Subst Abuse Treat; 2023 Jan; 144():108923. PubMed ID: 36334383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report.
    Guillou-Landreat M; Dany A; Challet-Bouju G; Laforgue E; Leboucher J; Benoit Hardouin J; Victorri-Vigneau C; Grall-Bronnec M
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
    Reimer J; Vogelmann T; Trümper D; Scherbaum N
    Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. French general practitioners' prescribing high-dosage buprenorphine maintenance treatment: is the existing training (good) enough?
    Feroni I; Peretti-Watel P; Masut A; Coudert C; Paraponaris A; Obadia Y
    Addict Behav; 2005 Jan; 30(1):187-91. PubMed ID: 15561460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Buprenorphine for the treatment of opioid dependence: a study on generic substitution conducted in community pharmacies].
    Julians-Minou G; Bruch S; Peyre N; Sudérie G; Lapeyre-Mestre M; Roussin A
    Therapie; 2010; 65(3):241-7. PubMed ID: 20699077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France.
    Driot D; Ouhayoun S; Perinelli F; Grézy-Chabardès C; Birebent J; Bismuth M; Dupouy J
    Therapie; 2019 Oct; 74(5):537-546. PubMed ID: 31030902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
    Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
    Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
    Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
    J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing patterns of buprenorphine waivered physicians.
    Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
    Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient satisfaction with clinic-based medication pick up: Addressing pharmacy-level challenges to buprenorphine access.
    Kolb E; Rueth M
    J Opioid Manag; 2021; 17(7):77-86. PubMed ID: 34520029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
    Strang J; Manning V; Mayet S; Ridge G; Best D; Sheridan J
    Addiction; 2007 May; 102(5):761-70. PubMed ID: 17506153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.